| 1 | PARK5, UCHL1
|
| Aberrant interaction between Parkinson disease-associated mutant UCH-L1 and the lysosomal receptor for chaperone-mediated autophagy.
|
| Kabuta T, Furuta A, Aoki S, Furuta K, Wada K.
|
| J Biol Chem 283(35):23731-8. Epub 2008 Jun 12.
2008
|
| 2 | UCHL1, PARK5
|
| Aberrant molecular properties shared by familial Parkinson's disease-associated mutant UCH-L1 and carbonyl-modified UCH-L1.
|
| Kabuta T, Setsuie R, Mitsui T, Kinugawa A, Sakurai M, Aoki S, Uchida K, Wada K.
|
| Hum Mol Genet 17(10):1482-96. Epub 2008 Feb 4. 2008
|
| 3 | DYT3, FTDP17, FTDU17, FXTAS, LRRK2, MAPT, PARK1, PARK4, PARK5, PARK6, PARK7, PARK8, PINK1, PRKN, PSRP, SNCA, UCHL1
|
| Genetics of Parkinson disease: paradigm shifts and future prospects.
|
| Farrer MJ.
|
| Nat Rev Genet 7(4):306-18. 2006
|
| 4 | PARK1, PARK3, PARK4, PARK5, PARK6, PARK7, PARK8, PARK9, PRKN
|
| Molecular pathogenesis of Parkinson's disease.
|
| Gandhi S, Wood NW.
|
| Hum Mol Genet 14(18):2749-55. Epub 2005 Aug 26. 2005
|
| 5 | PARK1, PARK10, PARK11, PARK3, PARK5, PARK6, PARK7, PARK8, PARK9, PRKN
|
| Parkin genetics: one model for Parkinson's disease.
|
| Mata IF, Lockhart PJ, Farrer MJ.
|
| Hum Mol Genet 13 Spec No 1:R127-33. Epub 2004 Feb 19. 2004
|
| 6 | AD1, AD2, AD3, AD4, AD5, AD6, AD9, PARK1, PARK11, PARK3, PARK4, PARK5, PARK6, PARK7, PARK8, PARK9, PRKN
|
| Chasing genes in Alzheimer's and Parkinson's disease.
|
| Bertoli-Avella AM, Oostra BA, Heutink P.
|
| Hum Genet 114(5):413-38. Epub 2004 Mar 04. 2004
|
| 7 | UCHL1, PARK5
|
| The UCH-L1 gene encodes two opposing enzymatic activities that affect alpha-synuclein degradation and Parkinson's disease susceptibility.
|
| Liu Y, Fallon L, Lashuel HA, Liu Z, Lansbury PT Jr.
|
| Cell 111(2):209-18. 2002
|
| 8 | PARK5, UCHL1
|
| Methylation status in the promoter region of the human PGP9.5 gene in cancer and normal tissues.
|
| Bittencourt Rosas SL, Caballero OL, Dong SM, da Costa Carvalho Mda G, Sidransky D, Jen J.
|
| Cancer Lett 170(1):73-9. 2001
|